Delivery Order SPE2DB24D2105-SPE2DB24FAQCW
Award Date
9/24/24
Potential Completion Date
9/25/24
Potential Value
$54K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $38,691.31, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Dupixent 300 mg/2 ml pens to the government. Amerisourcebergen is a major pharmaceutical distribution company that holds a large Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, to provide a wide range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Dupixent 300 mg/2 ml pens. The $13,816.86 firm-fixed-price delivery order has an ultimate completion date of August 7, 2024. The contract is not designated with any set-aside requirements, indicating it was open to full and open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract with the...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $15,701.69 for the supply of Dupixent 300 mg/2 ml pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 19, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $9,655.91 firm fixed-price delivery order is for the supply of the medication Dupixent (300 mg/2 ml pen, 2 ml) to DLA facilities. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award, valued at $15,850.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Dupixent 300 mg/2 ml pen, with an ultimate completion date of May 8, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,640.09, is a Delivery Order contract for the supply of the specialty medication Dupixent 300 mg/2 ml pen. The contract has a completion date of February 12, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,317.88 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a specialty medication. The contract has an ultimate completion date of July 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Dupixent 300 mg/2 ml pens. The contract has a firm fixed price of $41,843.17 and an ultimate completion date of August 29, 2024. This delivery order contract is not set aside for any specific business type. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,864.81 delivery order contract is for the supply of the prescription medication Dupixent 300 mg/2 ml pen. The contract is a firm fixed-price delivery order without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,191.65 firm fixed price delivery order is for the supply of Dupixent 300 mg/2 ml pen medication. The contract has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...